|
Other names: Eyelash enhancer, a form of bimatoprost (also marketed in another from as the eyedrop Lumigan® (Allergan) used in the treatment of glaucoma)
Goal: Lattise (Allergan) is the first FDA-approved pharmaceutical designed to enhance the appearance of the thin eyelashes by promoting eyelash growth.
Application: Latisse is a liquid that is dabbed onto the base of the upper lashes nightly using a special applicator.
It should not be applied to the eye or when wearing contact lenses. If any of the liquid spills onto the skin, it should be blotted off with cotton or Q-tips.
Use of Latisse should be avoided during pregnancy and nursing.
Eyelash growth and thickening generally become noticeable anywhere from 6 to 16 weeks after beginning treatment.
Advantages: Latisse offers a more natural-appearing and safer method for enhancing thinned eyelashes as compared to permanent eyeliner a (tattoo) or eyelash implants (a hair transplant procedure). The exact mechanism of action is unknown but is probably related to increasing the percentage of lashes that are in their growth phase (anagen).
Limitations: The effect of Latisse on the eyelashes is temporary and will disappear if the medication is discontinued. If Latisse is applied to the skin, it may cause reversible darkening and uninteded hair growth. If applied to the eye, it may result in non-reversible darkening of the iris. Eye itching and redness are not uncommon (about 4% of patients). Patients with eye problems (glaucoma, inflammation, etc) should check with their eye doctor before starting use.
Comments: As widespread use of this medication is new, long-term side effects, if any, are unknown. However, with the more powerful glaucoma form of this chemical compound, adverse effects have been relatively mild and fleeting. Of course, long-term daily application of a medication known to affect eyeball pressure as well as melanin pigment production inside of the eye may not appeal to all people.
|
